Analysis of three strategies to increase screening coverage for cervical cancer in the general population of women aged 60 to 70 years: the CRICERVA study

被引:15
作者
Acera, Amelia [1 ,2 ,3 ,4 ]
Maria Manresa, Josep [2 ,5 ]
Rodriguez, Diego [1 ]
Rodriguez, Ana [1 ]
Maria Bonet, Josep [6 ]
Sanchez, Norman [7 ]
Hidalgo, Pablo [6 ]
Soteras, Pilar [1 ]
Toran, Pere [2 ]
Trapero-Bertran, Marta [8 ]
Lozano, Iris [3 ]
De Sanjose, Silvia [9 ,10 ]
机构
[1] Inst Catala Salut, SAP Cerdanyola Ripollet, Barcelona, Spain
[2] IDIAP Jordi Gol, Unitat Suport Recerca Metropolitana Nord, Barcelona, Spain
[3] Univ Autonoma Barcelona, E-08193 Barcelona, Spain
[4] Generalitat Catalunya, IDIAP Jordi Gol, GRASSIR Res Grp, Barcelona, Spain
[5] Univ Autonoma Barcelona, Dept Infermeria, E-08193 Barcelona, Spain
[6] SAP Valles OccidentalInst Catala Salut, Barcelona, Spain
[7] Inst Catala Salut, SAP Valles Occidental, Barcelona, Spain
[8] Univ Pompeu Fabra, Ctr Res Econ & Hlth CRES, Barcelona, Spain
[9] Inst Catala Oncol, Unit Infect & Canc, Barcelona, Spain
[10] CIBER Epidemiol & Salud Publ, Madrid, Spain
关键词
Clinical trial; Experimental study; Population coverage; Population screening; Cervical cancer; Cervical cytology; HUMAN-PAPILLOMAVIRUS;
D O I
10.1186/1472-6874-14-86
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Cervical cancer is a frequently diagnosed cancer in women worldwide. Despite having easy preventive and therapeutic approaches, it is an important cause of mortality among women. Methods: The CRICERVA study is a cluster clinical trial which assigned one of three interventions to the target population registered in Cerdanyola, Barcelona. Among the 5,707 resident women aged 60 to 70 years in the study area, women with no record of cervical cytology over the last three years were selected. The study included four arms: three interventions all including a pre-assigned date for screening visit and i) personalized invitation letter; ii) adding to i) an informative leaflet; and, iii) in addition to ii) a personalized appointment reminder phone call, and iv) no specific action taken (control group). Participants were offered a personal interview about social-demographic characteristics and about screening attitudes. Cervical cytology and HPV DNA test (HC2) were offered as screening tests. In the case of screening positive in any of these tests, the women were followed up until a full diagnosis could be obtained. The effect size of each study arm was estimated as the absolute gain in coverage between the original coverage and the final coverage. Results: From the intervention groups (4,775 women), we identified 3,616 who were not appropriately screened, of which 2,560 women answered the trial call and 1,376 were amenable to screening. HPV was tested in 920 women and cervical cytology in all 1,376. Overall, there was an absolute gain in coverage of 28.8% in the intervention groups compared to 6% in the control group. Coverage increased from 51.2% to 76.0% in strategy i); from 47.4% to 79.0% in strategy ii) and from 44.5% to 74.6% in strategy iii). Lack of information about the relevance of screening was the most important factor for not attending the screening program. Conclusions: The study confirms that actively contacting women and including a date for a screening visit, notably increased participation in the screening program. Efforts to improve health education in preventative activities are warranted.
引用
收藏
页数:8
相关论文
共 21 条
[1]   Economic evaluation of three populational screening strategies for cervical cancer in the county of Valles Occidental: CRICERVA clinical trial [J].
Acera, Amelia ;
Rodriguez, Ana ;
Trapero-Bertran, Marta ;
Soteras, Pilar ;
Sanchez, Norman ;
Bonet, Josep M. ;
Manresa, Josep M. ;
Hidalgo, Pablo ;
Toran, Pere ;
Prieto, Gemma .
BMC HEALTH SERVICES RESEARCH, 2011, 11
[2]   Patterns of intra-cluster correlation from primary care research to inform study design and analysis [J].
Adams, G ;
Gulliford, MC ;
Ukoumunne, OC ;
Eldridge, S ;
Chinn, S ;
Campbell, MJ .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2004, 57 (08) :785-794
[3]   Description of the national situation of cervical cancer screening in the member states of the European Union [J].
Anttila, Ahti ;
Ronco, Guglielmo .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (15) :2685-2708
[4]   Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer [J].
Arbyn, Marc ;
Ronco, Guglielmo ;
Anttila, Ahti ;
Meijer, Chris J. L. M. ;
Poljak, Mario ;
Ogilvie, Gina ;
Koliopoulos, George ;
Naucler, Pontus ;
Sankaranarayanan, Rengaswamy ;
Peto, Julian .
VACCINE, 2012, 30 :F88-F99
[5]   In situ and invasive cervical cancer epidemiology in the province of Girona, Spain 1990-2004: incidence, mortality, survival and screening history [J].
Castro Marqueta, Pilar ;
Moreno-Crespi, Judit ;
Buxo-Pujolras, Maria ;
Cervantes-Amat, Marta ;
Perez-Gomez, Beatriz ;
Marcos-Gragera, Rafael .
MEDICINA CLINICA, 2011, 136 (05) :192-198
[6]   Age at sexual initiation and number of sexual partners in the female Spanish population Results from the AFRODITA survey [J].
de Sanjose, Silvia ;
Cortes, Xavier ;
Mendez, Cristina ;
Puig-Tintore, Lluis ;
Torne, Aureli ;
Roura, Esther ;
Xavier Bosch, F. ;
Castellsague, Xavier .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2008, 140 (02) :234-240
[7]  
Sanjosé Silvia de, 2006, Gac Sanit, V20, P166
[8]   Screening history preceding a diagnosis of cervical cancer in women age 65 and older [J].
Dinkelspiel, Helen ;
Fetterman, Barbara ;
Poitras, Nancy ;
Kinney, Walter ;
Cox, J. Thomas ;
Lorey, Thomas ;
Castle, Philip E. .
GYNECOLOGIC ONCOLOGY, 2012, 126 (02) :203-206
[9]  
European CDC (ECDC), 2008, GUIDANCE FOR THE INT, P1
[10]   Interventions targeted at women to encourage the uptake of cervical screening [J].
Everett, Thomas ;
Bryant, Andrew ;
Griffin, Michelle F. ;
Martin-Hirsch, Pierre P. L. ;
Forbes, Carol A. ;
Jepson, Ruth G. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (05)